Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?
- PMID: 32928023
- PMCID: PMC7495939
- DOI: 10.1177/1470320320957157
Could angiotensin-converting enzyme 1 I/D polymorphism be a modificator of COVID-19 response in different populations, diseases, and/or conditions?
References
-
- Delanghe JR, Speeckaert MM, De Buyzere ML. COVID-19 infections are also affected by human ACE1 D/I polymorphism. Clin Chem Lab Med 2020; 58(7): 1125–1126. - PubMed
-
- Saadat M. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection. Clin Chem Lab Med 2020; 58(7): 1127–1128. - PubMed
-
- Delanghe JR, Speeckaert MM, De Buyzere ML. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19. Clin Chem Lab Med 2020; 58(7): 1129–1130. - PubMed
-
- Gemmati D, Bramanti B, Serino ML, et al. COVID-19 and individual genetic susceptibility/receptivity: role of ACE1/ACE2 genes, immunity, inflammation and coagulation. Might the double X-chromosome in females be protective against SARS-CoV-2 compared to the single X-chromosome in males? Int J Mol Sci 2020; 21: E3474. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
